Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you’re still in the know with MassDevice +7.
7. Siemens reveals probe into Russian payments, diagnostics business
Global engineering giant Siemens reveals a new investigation into payments made to employees at a Russian facility and a U.S. probe into the company’s diagnostics business.
6. Med-tech trends: The most talked about device makers in April
April’s headlines were dominated by Stryker, Medtronic, Covidien, St. Jude Medical and Boston Scientific.
5. GOP govs ask Senate, House leaders to kill medical device tax
A quintet of Republican governors is asking Congressional leaders today to repeal the medical device tax, saying the 2.3% levy on U.S. med-tech sales runs "counter to principles of economic growth and job creation."
4. Masimo CEO Kiani on why the med-tech industry should protect its young
Medical device maverick Joe Kiani, founder & CEO of patient monitoring pioneer Masimo, speaks out in favor of a tiered system designed to protect small companies from being squashed by the 2.3% medical device tax, reviving a long-abandoned tactic for fighting the top-line levy.
3. Edwards wins CMS Medicare coverage for Sapien TAVI system
The Centers for Medicare & Medicaid affirm coverage for transcatheter aortic valve implantation systems, such as Edwards Lifesciences’ landmark Sapien device, with a few caveats.
2. Is Johnson & Johnson eyeing Edwards, St. Jude?
Johnson & Johnson, already the world’s largest health products maker, could have its eye on Edwards Lifesciences and St. Jude Medical as potential acquisitions, analysts say.
1. Are Medtronic’s CRM layoffs a sign of a prolonged slump?
Medtronic confirms that it will cut about 220 jobs from its cardiac rhythm management business, a division that saw a 9% decrease in the company’s latest earnings report.
